Cite
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report
MLA
Michael Byrne, et al. “Reduced Intensity Conditioning for Acute Myeloid Leukemia Using Melphalan- vs Busulfan-Based Regimens: A CIBMTR Report.” Blood Advances, vol. 4, July 2020, pp. 3180–90. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....206e8ff6ed3071549ebdf616172fcb8c&authtype=sso&custid=ns315887.
APA
Michael Byrne, Jane L. Liesveld, Richard F. Olsson, Sagar S. Patel, Hongtao Liu, Eric Wong, Brenda M. Sandmaier, Bipin N. Savani, Hannah Choe, Partow Kebriaei, Gulrayz Ahmed, Tania Jain, Moussab Damlaj, Rebecca L. Olin, Mehdi Hamadani, Uday R. Popat, Neil Palmisiano, Rajneesh Nath, Mei-Jie Zhang, … Wael Saber. (2020). Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Advances, 4, 3180–3190.
Chicago
Michael Byrne, Jane L. Liesveld, Richard F. Olsson, Sagar S. Patel, Hongtao Liu, Eric Wong, Brenda M. Sandmaier, et al. 2020. “Reduced Intensity Conditioning for Acute Myeloid Leukemia Using Melphalan- vs Busulfan-Based Regimens: A CIBMTR Report.” Blood Advances 4 (July): 3180–90. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....206e8ff6ed3071549ebdf616172fcb8c&authtype=sso&custid=ns315887.